SCHEMBL30337987

SCHEMBL30337987

COc1ccc2nccc(N3CCC4(CC3)OCCO4)c2c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 2/20 0.65
ALDH1A1 P00352 10/20 0.57
LMNA P02545 3/20 0.55
CES2 O00748 1/20 0.50
GAA P10253 2/20 0.46
KDM4E B2RXH2 6/20 0.44
POLB P06746 3/20 0.44
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPK1 P28482 1/20 0.43
HCRTR1 O43613 1/20 0.42
HPGD P15428 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
ATM Q13315 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22455074 0.84 NCF1 (0.64) NCF1ALDH1A1GAAHTT
SCHEMBL29354433 0.84 NCF1 (0.64) NCF1ALDH1A1GAAHTT
SCHEMBL22395599 0.80 ALDH1A1 (0.56) NCF1ALDH1A1LMNACES2GAA
SCHEMBL6636311 0.79 NCF1 (1.00) NCF1GAAHSD17B10
SCHEMBL22495842 0.78 ADRB2 (0.58) NCF1ALDH1A1LMNAKDM4EHTT
SCHEMBL22395799 0.77 ALDH1A1 (0.68) ALDH1A1LMNACES2KDM4EPOLB
SCHEMBL4273949 0.76 KDM4E (0.59) ALDH1A1LMNACES2KDM4EHPGD
SCHEMBL14539369 0.76 ALDH1A1 (0.45) NCF1ALDH1A1LMNAKDM4ENPSR1
SCHEMBL1223373 0.76 NCF1 (0.64) NCF1ALDH1A1LMNAGAAKDM4E
SCHEMBL22395854 0.76 ALDH1A1 (0.68) ALDH1A1LMNACES2KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230079399-A1 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS THE US SECRETARY DEPARTMENT OF H (US) 2023-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230079399-A1 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS ALDH1A1, ALDH1A2, ALDH2 NCF1 600/4885ALDH1A1 1/4885LMNA 4401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.